Asimily vs Cylera
Updated October 16, 2026
Hospital security and biomedical engineering teams that need to know which connected devices are on the network often compare Asimily and Cylera. Both find medical devices and rank their risk, but Asimily emphasizes fixing devices without taking them out of service, while Cylera is known for building a device inventory hospitals can trust. Where your program is weakest today usually points to the answer.
Our analysts compared Asimily and Cylera on device inventory, risk ranking, remediation, industries served, setup, and pricing, using the HIR review of each company and Asimily's own blog. In the following sections, we compare them closely, describe the hospital each suits, and note Asimily's recent release.
Asimily vs Cylera at a glance, October 2026
| What buyers weigh | Asimily | Cylera |
|---|---|---|
| Pricing model | A license for the device security platform, often based on the number of devices or sites. | A subscription priced by number of devices or beds, with packages for systems with several hospitals. |
| What drives cost | How many devices and sites are covered, the network sensors or collectors needed, and consulting services. | The number of connected devices and hospital sites, and any help connecting to the network. |
| Building a device list you can trust | Inventory coverage is part of an outcomes score of 7.3. | Inventory is its strongest mark at 7.6, aimed at hospitals that do not trust their current device list. Higher score |
| Ranking device risk | Risk is weighed against how often each device is used, which feeds a product score of 7.4. | Risk is scored with clinical context so security and biomed share one view, which scores 7.5. |
| Fixing devices without disrupting care | Its remediation workflow is built around closing fixes without taking needed devices offline. Clear edge | Fixes depend on the team getting change windows and clinical uptime rules in place. |
| Industries covered | Asimily also sells its platform to manufacturers, utilities, and other industries with networked equipment. | Cylera is built for hospitals that want a healthcare-specific platform. |
| Setting it up | Setup needs network visibility and an owner for each group of devices, which scores 6.8. | Setup needs network taps and clinical uptime rules, which scores 7.0. |
| Time to full value | About 7 to 15 months | About 5 to 11 months |
| What you need first | Biomedical engineering and security staff working from the same list of fixes. | A way to see traffic on the network segments where clinical devices sit. |
| Deal-breaker | You mainly need clinician sign-in and single sign-on, as Imprivata offers. | You mainly need single sign-on or clinician identity tools, not a device list. |
| Pricing clarity score | 6.9 | 7.1 |
| HIR overall score | 7.2, Recommend. | 7.4, Recommend. |
| Best for | Health systems where biomedical engineering and security will fix device risks together. | Hospitals that need an accurate list of connected medical devices before they can patch or segment them. |
| Not a fit for | Organizations with no biomedical engineering owner to carry out device fixes. | Buyers that expect a full managed security operations center inside the same product. |
Which fits which buyer
Ask whether your problem is finding devices or fixing them.
Choose Asimily if
- Biomedical engineering and security will work on fixes together.
- You want segmentation that keeps up as devices change.
- You also run manufacturing or other networked equipment.
Choose Cylera if
- You do not trust your current device list.
- You want a platform built only for hospitals.
- You want a first-site pilot before a wider contract.
Verdict
Cylera scores slightly higher and suits hospitals starting with an unreliable inventory. Asimily fits programs that know their devices and need to close fixes without disrupting care.
Neither replaces a managed security operations center.
Where the two tools are headed in 2027 and beyond
Asimily: Asimily introduced continuous segmentation, which updates network policies as devices change, on August 25, 2026.
Ask each to run a short discovery on one site and compare the device counts.
Methodology
Each row comes from the HIR reviews of Asimily and Cylera, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for Asimily or Cylera was checked on that vendor's own site on October 16, 2026.
A green check marks a clear edge for Asimily or Cylera only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either Asimily or Cylera are left out, and time to full value for each adds up the rollout stages in its review.